The present study aimed to assess the function and mechanism of TNFR2 in PDAC and the potential of a combination of TNFR2 blockade and PD-L1 blockage to treat pancreatic cancer. This evidence concerns the gene TNFRSF1B and familial pancreatic carcinoma.